MCHS NORTHLAND — History
CCN 521315 | 3-year financial timeline | COVID resilience: 75/100
🛡️ Public data only — no PHI permitted on this instance.
$87M
Latest Revenue (FY2022)
+10.1%
Revenue CAGR (3yr)
10.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $72M | $90M | $87M | -3.6% | +10.1% |
| Operating Expenses | $69M | $80M | $78M | -2.8% | +6.0% |
| Operating Margin | 3.7% | 11.4% | 10.6% | -6.8% | +70.4% |
| Net Income | $3M | $10M | $9M | -10.2% | +87.6% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 5,679 | 5,845 | 4,752 | -18.7% | -8.5% |
| Medicare Day % | 61% | 59% | 56% | -5.5% | -4.3% |
| Medicaid Day % | 6% | 7% | 7% | -3.9% | +5.5% |
COVID Impact & Recovery
Resilience Score: 75/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +21.1% ($72M → $87M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.1%
This Hospital
+7.6%
State Avg
Latest Margin
10.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $95M | 14.1% |
| FY2024 (proj) | $102M | 17.6% |
| FY2025 (proj) | $110M | 21.1% |